Scott Michael Habig serves as Executive at Aurinia Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Scott Michael Habig has executed 6 insider transactions totaling $308.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 6, 2024 involved selling 18,249 shares valued at $96.9K.
Scott Michael Habig currently holds 456,338 shares of Aurinia Pharmaceuticals Inc. (AUPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Michael Habig has been a net seller of AUPH stock. They have purchased $25.1K and sold $283.4K worth of shares.
Scott Michael Habig's most recent insider trade was on Aug 6, 2024, when they sold 18,249 shares at $5.31 per share.
Get notified when new Form 4 filings are submitted
| $5.60 |
| Discretionary |
| Feb 20, 2024 | AUPH | $0 | Award | 195,512 | $N/A | Discretionary |
| Feb 20, 2024 | AUPH | $87.0K | Sale | 15,867 | $5.48 | Discretionary |
| Mar 2, 2023 | AUPH | $0 | Award | 170,188 | $N/A | Discretionary |
| Nov 9, 2022 | AUPH | $25.1K | Purchase | 5,000 | $5.02 | Discretionary |